Form4insider filings, from the source

Insider holders · CIK 0001351288

GW PHARMACEUTICALS PLC · GWPH

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Geoffrey W Dr GuyExecutive Chairman8,141,521103,9258,245,446Mar 5, 2019 · 9:05 pm ESTForm 4
Justin D. GoverChief Executive Officer381,7732,143,3142,525,087Feb 28, 2019 · 5:02 pm ESTForm 4
Julian S GangolliPresident, North America106,548—106,548Feb 28, 2019 · 5:09 pm ESTForm 4
Adam D. GeorgeSecretary10,00021,69631,696Nov 23, 2018 · 4:30 pm ESTForm 4
James NobleDirector27,500—27,500Oct 1, 2018 · 6:39 am EDTForm 3
Scott M. GiacobelloChief Financial Officer10,536—10,536Feb 28, 2019 · 5:00 pm ESTForm 4
Volker KnappertzChief Medical Officer8,736—8,736Mar 5, 2019 · 9:06 pm ESTForm 4
Douglas B. SnyderChief Legal Officer4,968—4,968Feb 28, 2019 · 5:00 pm ESTForm 4
Cabot BrownDirector3,636—3,636Mar 5, 2019 · 9:09 pm ESTForm 4
Christopher J. ToveyChief Operating Officer2,503—2,503Oct 1, 2018 · 6:41 am EDTForm 3

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.